Notify me when PharVision Advisers, LLC files a new 13F portfolio report.
⭐ Subscribe ⭐| Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Filing Time |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 667 | $197,537,877 | +$137,645,260 | -$118,333,436 | +$19,311,824 | EXLS, DK, FVRR, ASAN, AVGO | 13F-HR | 17 Feb 2026, 16:21 |
| Q3 2025 | 654 | $177,748,923 | +$157,817,722 | -$49,567,853 | +$108,249,869 | W, EXLS, TIGR, ARRY, SFM | 13F-HR | 14 Nov 2025, 17:32 |
| Q2 2025 | 267 | $69,607,395 | +$52,801,281 | -$56,175,908 | -$3,374,627 | EXLS, META, CRUS, MNST, VEEV | 13F-HR | 13 Aug 2025, 14:15 |
| Q1 2025 | 259 | $72,095,249 | +$49,661,045 | -$94,725,244 | -$45,064,199 | EXLS, ADSK, QCOM, NVGS, GSL | 13F-HR | 15 May 2025, 12:50 |
| Q4 2024 | 380 | $118,274,344 | $0 | $0 | $0 | EXLS, VZ, CSGS, CXW, NFLX | 13F-HR | 14 Feb 2025, 17:51 |